Chemo Pharma Laboratories Ltd Financials

Chemo Pharma Laboratories Ltd Financial Statement

Chemo Pharma Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	0.63	0.30	0.25
Operating Expense	0.02	0.05	0.09
Net Profit	0.61	0.25	-0.29
Net Profit Margin	96.83	83.33	-116.00
Earning Per Share	4.07	1.64	-1.94
EBIDTA	0.61	0.25	-0.02
Effective Tax Rate	TBA	TBA	180.00

Particulars	Sep 2024
Revenue	0.63
Operating Expense	0.02
Net Profit	0.61
Net Profit Margin	96.83
Earning Per Share	4.07
EBIDTA	0.61
Effective Tax Rate	TBA

Chemo Pharma Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	TBA	TBA	TBA
Operating Expenses Annual	0.19	0.21	0.41
Operating Profit Annual	1.65	0.09	0.38
Interest Annual	TBA	TBA	TBA
Depreciation	0.01	0.01	0.02
Net Profit Annual	1.20	0.05	0.56
Tax Annual	0.44	0.03	-0.20

Particulars	Mar 2024
Total Revenue Annual	TBA
Operating Expenses Annual	0.19
Operating Profit Annual	1.65
Interest Annual	TBA
Depreciation	0.01
Net Profit Annual	1.20
Tax Annual	0.44

Chemo Pharma Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.56	0.69	2.17
Cash Flow from Operations	0.72	-0.68	-0.33
Cash Flow from Investing	-0.52	0.63	0.97
Cash Flow from Financing	-0.15	-0.08	-2.12
Cash Flow at the End	0.61	0.56	0.69

Particulars	Mar 2024
Cash Flow at the Beginning	0.56
Cash Flow from Operations	0.72
Cash Flow from Investing	-0.52
Cash Flow from Financing	-0.15
Cash Flow at the End	0.61

Chemo Pharma Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	TBA	TBA	TBA
PBIT Margin (%)	TBA	TBA	TBA
PBT Margin (%)	TBA	TBA	TBA
Net PROFIT Margin (%)	TBA	TBA	TBA
Return On Networth / Equity (%)	9.84	0.43	3.37
Return On Networth /Employed (%)	13.44	0.78	1.33
Return On Assets (%)	TBA	TBA	TBA
Total Debt / Equity (X)	TBA	TBA	TBA
Asset Turnover Ratio (%)	TBA	TBA	TBA

Particulars	Mar 2024
PBDIT Margin (%)	TBA
PBIT Margin (%)	TBA
PBT Margin (%)	TBA
Net PROFIT Margin (%)	TBA
Return On Networth / Equity (%)	9.84
Return On Networth /Employed (%)	13.44
Return On Assets (%)	TBA
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	TBA

Chemo Pharma Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.02	0.03	0.04
Total Current Assets Annual	6.25	6.13	6.30
Non Current Assets Annual	6.76	5.49	5.37
Total Shareholders Funds Annual	12.80	11.60	11.55
Total Assets Annual	13.02	11.62	11.66

Particulars	Mar 2024
Fixed Assets Annual	0.02
Total Current Assets Annual	6.25
Non Current Assets Annual	6.76
Total Shareholders Funds Annual	12.80
Total Assets Annual	13.02

Chemo Pharma Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 24, 2024, Chemo Pharma Laboratories Ltd has a market capitalization of 9.75 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Chemo Pharma Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , Chemo Pharma Laboratories Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Chemo Pharma Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and NaN% annually, respectively..

Chemo Pharma Laboratories Ltd's current PE ratio is 8.13.

Chemo Pharma Laboratories Ltd's ROCE averaged 5.5% from the FY ending March 2022 to 2024, with a median of 3.2%. It peaked at 12.8% in March 2024, reflecting strong capital efficiency over the period..

Chemo Pharma Laboratories Ltd's latest EBIT is Rs. 1.64 Cr, surpassing the average EBIT of Rs. 0.69 Cr over the 5 years..